A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease)

NCT00304291 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Neuromyelitis Optica
Myelitis, Transverse
Demyelinating Autoimmune Diseases, CNS
Autoimmune Diseases of the Nervous System

Interventions

DRUG: Mitoxantrone

Sponsor

State University of New York at Buffalo

Collaborators

[object Object]